WASHINGTON U.S. President Donald Trump acknowledged that a lack of support from four Senate Republicans leaves the party's healthcare overhaul on a "very, very narrow path" to passage, but signaled a willingness to work with them to make changes.
- USDA finds abscesses, unidentified material in raw Brazil beef: USDA
- Health insurers says Senate bill's Medicaid cuts to hurt states
- Saudi crown prince donates $66 million to fight Yemen cholera epidemic
- Novartis breast cancer drug Kisqali wins European panel backing
- High hopes ride on marijuana painkillers amid opioid crisis
PORT-AU-PRINCE, Haiti The United Nations stressed on Thursday its support for eradicating cholera in Haiti, an epidemic it accidentally started, although the government said residents would be better served if aid funding was channeled through it.
WASHINGTON The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery.
COPENHAGEN Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved GLP-1 drug called semaglutide, showed a weight loss of up to 13.8 percent in people with severe conditions.
(Reuters Health) - Hospitals and other healthcare facilities don’t consistently follow guidelines to ensure the safety of therapy animals and the people they aim to help, according to a survey of U.S. hospitals, eldercare facilities, and therapy animal organizations.